Xuerong Biotechnology(SZ:300511) Huan Qiu Wang·2026-01-07 07:37Core Viewpoint - Shanghai Xuerong Biotechnology Co., Ltd. has successfully developed a new strain of white enoki mushroom, X139, marking a significant breakthrough in overcoming the reliance on foreign strains in this field [1][3]. Group 1: Breakthrough and Achievements - The new strain X139 is a key achievement of the national breeding joint attack during the 14th Five-Year Plan period, led by Xuerong Biotechnology in collaboration with various research institutions [3]. - The X139 strain has surpassed Japanese strains in key performance metrics and has been granted a national invention patent, providing legal protection for technological innovations [3]. Group 2: Production and Market Impact - Since its industrial application began in June 2025, the X139 strain has achieved a production scale of 1,200 tons per day, accounting for approximately 30% of the national factory production total of enoki mushrooms [5]. - The successful entry of Xuerong's enoki mushrooms into the Japanese market is a significant shift, as products using imported strains were previously restricted from this market [5]. Group 3: Future Plans and Industry Goals - The company aims to increase the industry coverage of domestically developed high-quality strains to over 70%, promoting the benefits of national breeding achievements across the industry [5]. - Xuerong Biotechnology plans to enhance research and development investments and expand successful experiences to other edible mushroom varieties, contributing to a self-controlled modern commercial breeding system in China [7].